Zometa (zoledronic acid) Novartis
HomeZometa International Site: For Non US healthcare professionals onlyUS ResidentsCountry Sites


About ZOMETA

Key Clinical Trial and Recent Publications | Zometa

ZOMETA for Your Practice

For Your Patients

Professional Resource Center

ZOMETA Around the World
Videos
View videos on bone
metastases and the Zometa
mechanism of action

Learn more about the Zometa (Zoledronic Acid) mechanism of action

 
European Summary of Product Characteristics
For non-U.S. Healthcare Professionals: Get information about Zometa and its product characteristics

Learn more about ZOMETA product characteristics 		 
ZOMETA is the current standard of care for the prevention of skeletal-related events (SREs)
Disclaimer
 

The page you requested is intended for healthcare professionals outside the US.

PLEASE CHOOSE ONE

Zometa Information for International Healthcare Professionals Zometa Information for US residents Zometa Information for Patients Outside the US

 

Disclaimer: This is an international website for ZOMETA® (zoledronic acid). The information on this site is not country-specific, and may contain information that is outside the approved indications where you practice. Please contact your local Novartis representative for the latest product information specific to your country.

About ZOMETA | ZOMETA Clinical News | ZOMETA for Your Practice
Professional Resource Center | ZOMETA Around the World

About Novartis OncologySiteMapContactPrivacy
 


Use of this website is subject to our Terms of Use
© 2008 Novartis Pharma AG.